Firm |
Analyst |
Argus Research Corporation |
David Toung |
Bank of America |
Travis Steed |
Barclays |
Matthew Miksic |
Bernstein |
Lee Hambright |
BTIG |
Ryan Zimmerman |
Canaccord Genuity |
Caitlin Cronin |
Citi |
Joanne Wuensch |
Cleveland Research |
James Clow |
Deutsche Bank |
Philip Chickering |
Evercore ISI |
Vijay Kumar |
Goldman Sachs |
David Roman |
Jefferies |
Matthew Taylor |
JMP Securities |
David Turkaly |
J.P. Morgan |
Robert Marcus |
Morgan Stanley |
Andrew Ranieri |
Morningstar, Inc. |
Debbie Wang |
Needham & Company LLC. |
Michael Matson |
Nephron Research |
Christopher Pasquale |
Oppenheimer & Co. Inc. |
Steven M. Lichtman |
Piper Sandler & Companies |
Matthew O’Brien |
Raymond James |
Jayson Bedford |
RBC Capital Markets |
Shagun Singh Chadha |
Robert W. Baird & Co. Inc. |
Jeffrey Johnson |
Roth MKM |
Jason Wittes |
Stifel Nicolaus & Company, Inc. |
Frederick Wise |
TD Cowen |
Joshua Jennings |
Truist Securities |
Richard Newitter |
UBS Equities |
Danielle Antalffy |
Wells Fargo Securities, LLC |
Lawrence H. Biegelsen |
Wolfe Research |
Michael Polark |
Stryker Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Stryker Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Stryker Corporation or its management. Stryker Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.